Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,241
Closed -$203K 1101
2022
Q1
$203K Sell
2,241
-1,226
-35% -$116K 0.01% 1091
2021
Q4
$302K Sell
3,467
-323
-9% -$27.7K 0.01% 898
2021
Q3
$305K Sell
3,790
-6
-0.2% -$432 0.01% 849
2021
Q2
$271K Buy
3,796
+128
+3% +$9.49K 0.01% 898
2021
Q1
$263K Buy
+3,668
New +$240K 0.01% 887
2018
Q4
Sell
-3,006
Closed -$271K 833
2018
Q3
$271K Buy
3,006
+451
+18% +$43K 0.02% 674
2018
Q2
$232K Buy
+2,555
New +$245K 0.01% 724
2017
Q2
Sell
-3,195
Closed -$219K 724
2017
Q1
$219K Hold
3,195
0.02% 616
2016
Q4
$218K Buy
+3,195
New +$187K 0.02% 611

Other funds holding CMA

Raymond James Trust's CMA Position: Q2 2022 in Review

Raymond James Trust sold out of Comerica (CMA) in Q2 2022, closing a stake of 2,241 shares — an estimated $203K sold.

Raymond James Trust first reported a position in CMA in Q4 2016 and held it in 9 quarters. The position peaked at $305K in Q3 2021. 568 funds tracked by Wall St. Rank hold CMA as of Q2 2022.

  • Raymond James Trust reported no remaining Comerica position as of Q2 2022 after selling out during the quarter.
  • Raymond James Trust sold 2,241 Comerica shares in Q2 2022, an estimated $203K.
  • Raymond James Trust first reported a position in Comerica in Q4 2016 and held it in 9 quarters.
  • Raymond James Trust's Comerica position peaked at $305K in Q3 2021.
  • 568 funds tracked by Wall St. Rank held Comerica as of Q2 2022.

Based on Raymond James Trust's 13F filing for Q2 2022, filed 14 Jul 2022.